Hanlim Pharmaceutical Co., Ltd.

Catholic University Industry Academic Cooperation Foundation

Catholic University Academic Cooperation Foundation

Jun-Ki Min

Mi-La Cho

Jin-Ha Park

Geun-Hyeog Lee

Hye-Jwa Oh

Eun-Young Kwak

Yun-Ju Woo

Joo-Yeon Jhun

Byong-Sun Choi

Se-Wan Park

Young-Ok Jung

The present invention provides a method for preventing or treating osteoarthritis comprising administrating rebamipide or a pharmaceutical composition comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier to a subject in need thereof. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.

Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient

The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.

Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide

Growing community of inventors

Gyeonggi-do, South Korea

Jun-Ki Min